300 related articles for article (PubMed ID: 34704451)
1. circ_0067934 promotes the progression of papillary thyroid carcinoma cells through miR-1301-3p/HMGB1 axis.
Dong LP; Chen LY; Bai B; Qi XF; Liu JN; Qin S
Neoplasma; 2022 Jan; 69(1):1-15. PubMed ID: 34704451
[TBL] [Abstract][Full Text] [Related]
2. Circ_0002111 modulates the growth process of papillary thyroid carcinoma cells by targeting the miR-363-3p/HMGB1 axis.
Zhang Z; Mo Y; Wu L; Wang X; Liao G; Tan W; Li D
Anticancer Drugs; 2022 Oct; 33(9):923-934. PubMed ID: 36136992
[TBL] [Abstract][Full Text] [Related]
3. CircRTN1 stimulates HMGB1 to regulate the malignant progression of papillary thyroid cancer by sponging miR-101-3p.
Zheng M; Xu L; Wei C; Guan W
Hormones (Athens); 2023 Jun; 22(2):281-293. PubMed ID: 36826778
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ_0008274 enhances the malignant progression of papillary thyroid carcinoma via modulating solute carrier family 7 member 11 by sponging miR-154-3p.
Ma J; Kan Z
Endocr J; 2021 May; 68(5):543-552. PubMed ID: 33473055
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circ_0062389 modulates papillary thyroid carcinoma progression via the miR-1179/high mobility group box 1 axis.
Wang Y; Zong H; Zhou H
Bioengineered; 2021 Dec; 12(1):1484-1494. PubMed ID: 33926347
[TBL] [Abstract][Full Text] [Related]
6. Circ_0011373 promotes papillary thyroid carcinoma progression by regulating miR-1271/LRP6 axis.
Huang G; Mao L; Hu X
Hormones (Athens); 2023 Sep; 22(3):375-387. PubMed ID: 37378808
[TBL] [Abstract][Full Text] [Related]
7. Circ_0079558 promotes papillary thyroid cancer progression by binding to miR-26b-5p to activate MET/AKT signaling.
Zheng H; Fu Q; Ma K; Shi S; Fu Y
Endocr J; 2021 Nov; 68(11):1247-1266. PubMed ID: 34565758
[TBL] [Abstract][Full Text] [Related]
8. Circ_0059354 aggravates the progression of papillary thyroid carcinoma by elevating ARFGEF1 through sponging miR-766-3p.
Li Z; Xu J; Guan H; Lai J; Yang X; Ma J
J Endocrinol Invest; 2022 Apr; 45(4):825-836. PubMed ID: 34854069
[TBL] [Abstract][Full Text] [Related]
9. Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis.
Li Z; Huang X; Liu A; Xu J; Lai J; Guan H; Ma J
Life Sci; 2021 Jan; 264():118622. PubMed ID: 33203523
[TBL] [Abstract][Full Text] [Related]
10. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis.
Liu Y; Chen G; Wang B; Wu H; Zhang Y; Ye H
Endocr J; 2021 Jun; 68(6):713-727. PubMed ID: 33716239
[TBL] [Abstract][Full Text] [Related]
11. Silencing circ_0000644 inhibits papillary thyroid cancer cell malignancy by combining with miR-671-5p to release the inhibition on ANXA2.
Li HG; Zhao LH; Liu JZ; Liu KP; Liu JB; Su ZJ; Gao YJ
J Endocrinol Invest; 2023 Apr; 46(4):749-761. PubMed ID: 36224454
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of circPUM1 impedes cell growth, metastasis and glycolysis of papillary thyroid cancer via enhancing MAPK1 expression by serving as the sponge of miR-21-5p.
Li Y; Qin J; He Z; Cui G; Zhang K; Wu B
Genes Genomics; 2021 Feb; 43(2):141-150. PubMed ID: 33481227
[TBL] [Abstract][Full Text] [Related]
13. Circ_0000144 acts as a miR-1178-3p decoy to promote cell malignancy and angiogenesis by increasing YWHAH expression in papillary thyroid cancer.
Ma Y; Yang D; Guo P
J Otolaryngol Head Neck Surg; 2022 Jul; 51(1):28. PubMed ID: 35902926
[TBL] [Abstract][Full Text] [Related]
14. Circ_0003747 promotes thyroid cancer progression by sponging miR-338-3p to upregulate PLCD3 expression.
Dou XL; Xia FD; Li XY
Epigenetics; 2023 Dec; 18(1):2210339. PubMed ID: 37166441
[TBL] [Abstract][Full Text] [Related]
15. Circular RNA circ_0000644 promotes papillary thyroid cancer progression via sponging miR-1205 and regulating E2F3 expression.
Nie C; Han J; Bi W; Qiu Z; Chen L; Yu J; Pang R; Liu B; Sheng R; Zhang J
Cell Cycle; 2022 Jan; 21(2):126-139. PubMed ID: 34919034
[TBL] [Abstract][Full Text] [Related]
16. circ_0005273 promotes thyroid carcinoma progression by SOX2 expression.
Zhang W; Zhang H; Zhao X
Endocr Relat Cancer; 2020 Jan; 27(1):11-21. PubMed ID: 31693489
[TBL] [Abstract][Full Text] [Related]
17. Circ_0002111/miR-134-5p/FSTL1 signal axis regulates tumor progression and glycolytic metabolism in papillary thyroid carcinoma cells.
Zhang H; Jiang J; He X; Zhou Q
J Endocrinol Invest; 2023 Apr; 46(4):713-725. PubMed ID: 36227499
[TBL] [Abstract][Full Text] [Related]
18. Circ_0058124 Aggravates the Progression of Papillary Thyroid Carcinoma by Activating LMO4 Expression via Targeting miR-370-3p.
Liu L; Yan C; Tao S; Wang H
Cancer Manag Res; 2020; 12():9459-9470. PubMed ID: 33061633
[TBL] [Abstract][Full Text] [Related]
19. circRPS28 (hsa_circ_0049055) is a novel contributor for papillary thyroid carcinoma by regulating cell growth and motility via functioning as ceRNA for miR-345-5p to regulate frizzled family receptor 8 (FZD8).
Mao Y; Huo Y; Li J; Zhao Y; Wang Y; Sun L; Kang Z
Endocr J; 2021 Nov; 68(11):1267-1281. PubMed ID: 34108309
[TBL] [Abstract][Full Text] [Related]
20. circ_0007385 served as competing endogenous RNA for miR-519d-3p to suppress malignant behaviors and cisplatin resistance of non-small cell lung cancer cells.
Ye Y; Zhao L; Li Q; Xi C; Li Y; Li Z
Thorac Cancer; 2020 Aug; 11(8):2196-2208. PubMed ID: 32602212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
